will become a subsidiary of Nelnet and retain its brand identity.
Moline and Jeff Kuenne, Executive Vice President for Network Operations, will continue to lead ALLO
and its more than 100 associates.
The first production run of the Allo
will be made for the iPhone 5 series and is available to purchase on Kickstarter (https://www.
By adding Allos
to existing resellers Learning Well in Scandinavia and EDUTECH in the Middle East, Plateau provides local sales, implementation and support services to companies throughout the EMEA region.
is currently focused on the development and commercialization of FOLOTYN([R]) (pralatrexate injection), a folate analog metabolic inhibitor.
FOLOTYN (pralatrexate injection), a folate analogue metabolic inhibitor, was discovered by Memorial Sloan-Kettering Cancer Center, SRI International and Southern Research Institute and developed by Allos
Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer.
In accordance with the Agreement and Plan of Merger dated April 4, 2012 among Spectrum, Allos
and Sapphire Acquisition Sub, Inc.
SAN DIEGO -- Robbins Geller Rudman & Dowd LLP ("Robbins Geller") today announced that a class action has been commenced in the United States District Court for the District of Colorado on behalf of all persons who held shares of the common stock of Allos
is providing the information contained in the press release and conference call as of the date of the release and does not undertake any obligation to update any forward-looking statements as a result of new information, future events or otherwise.
Spectrum Pharmaceuticals (NASDAQ:SPPI) today announced that it commenced on Friday, April 13, 2012 a cash tender offer to purchase all of the outstanding shares of common stock of Allos
Spectrum Pharmaceuticals (NASDAQ: SPPI) and Allos
The proposed merger between AMAG and Allos
will be submitted to the respective stockholders of AMAG and Allos
for their consideration.
July 18 /PRNewswire-FirstCall/ -- Allos
The Board and shareholders of Allos
supported the proposed merger with AMAG based on the strategic rationale, anticipated operating synergies and potential for future growth of the core brands.